How to meditate on psychedelics with Vincent Horn of Meditate.io
May 17, 2018
Vincent Horn of Meditate.io talks about psychedelics and meditation.
Johns Hopkins studying effects of psilocybin on brains of long-term meditators
November 22, 2017
Are these states really similar? Many meditators have answered quite clearly, yes.
#32 – It’s All Red Flags: 5-MeO-DMT with Dr. Martin Ball
March 18, 2021
Psymposia editors discuss Dr. Martin Ball’s “session info” document that the retired 5-MeO-DMT practitioner sent to Psymposia. Dr. Ball has referenced the document in defense of his practices and cites it as evidence that his clients consented to him touching their genitals or vomiting on them while under the influence of 5-MeO-DMT.
Field Trip Announces “World’s First” Virtual Psychedelic Therapy, But Forgets To Mention They Aren’t the First and No Psychedelics Are Involved
April 25, 2020
Field Trip Ventures leads the charge to use “psychedelic” as a marketing buzzword for any kind of niche therapy.
Ibogaine Treatment Comes with Risks. We Had a Discussion About Safety with Medical Providers. | Part 10
January 3, 2018
The Ibogaine Conversation Part 10 | Unlike other psychedelic drugs, ibogaine is known to be potentially cardiotoxic. There are a number of fatalities associated with its use, and anyone considering working with it should be aware of the risks.
How psychedelic clinical trials are being affected by coronavirus
April 8, 2020
Almost all clinical psychedelic drug research is being affected in some way or another by COVID-19. But, response measures vary from one organization to the next.
It’s time to debunk prohibitionist narratives and calls for monopolies within psychedelic science
October 25, 2018
As venture-capital-backed, for-profit companies barrel into psychedelic therapy, the potential for the widespread privatization of psychedelic knowledge and profits looms large. Some researchers are so enthusiastic about medicalization by “any means necessary” that they’re resorting to prohibitionist historical narratives and calling for monopolies to push the agenda forward.
For someone who hasn’t taken a psychedelic drug it can be difficult to imagine what it’s like.
May 15, 2018
Think of a glass of water: under normal circumstances you might think ‘I drink water when I’m thirsty’. But when consuming a psychedelic substance you might think ’water is the essence of life’.
We talked with a researcher using psilocybin for cocaine addiction in Alabama
April 17, 2018
I came to a working hypothesis: at the center of the mystical experience is awe, wherein one is in the presence of something so great, so large, that it requires they completely reorder their mental structures - completely change the way they view reality.
Psychedelic medicines can help heal the trauma of mass incarceration
July 26, 2017
Psychedelic therapy has the potential to ignite a paradigm shift within our culture by enabling us to reframe complex social problems as manifestations of trauma.